Eledon Pharmaceuticals Prices $50 Million Public Offering of Common Stock and Pre-Funded Warrants

Leila Ahmed North America Legal Chronicle
Tagged:

O’Melveny & Myers LLP has advised Eledon Pharmaceuticals, Inc. Mintz has advised the underwriters. Eledon Pharmaceuticals, Inc. (Nasdaq: ELDN), a clinical-stage biotechnology company, has announced the…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here